Spring Bank Pharmaceuticals, Inc. (SBPH)
Spring Bank Pharmaceuticals, Inc. (SBPH)
$3.49 USD
Updated Sep 20 12:00am
Add SBPH to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
SBPH Stock Chart More Charts
SBPH Price/Volume Stats
| Current price | $3.49 |
| Prev. close | $3.69 |
| Day low | $3.32 |
| Day high | $3.71 |
| 50-day MA | $4.15 |
| 200-day MA | $7.42 |
| 52-week high | $15.00 |
| 52-week low | $3.32 |
| Volume | 89,400 |
| Avg. volume | 53,412 |
| Dividend yield | N/A |
| Market Cap | 57.44M |
Spring Bank Pharmaceuticals, Inc. (SBPH) Company Bio
Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of a class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. The company was founded in 2002 and is based in Milford, Massachusetts
Top Stories View All
Why this analyst just rated shares of HEXO a “buy”
What is the Worst Case Scenario for Stocks?
Best & Worst Performing Stock Industries for September 20, 2019
Best & Worst Performing Small Cap Stocks for September 20, 2019
Best & Worst Performing Mid Cap Stocks for September 20, 2019
View All Top Stories
Loading social stream, please wait...